Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

22 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Imipramine Articles

US FDA to update black box warnings for young adults taking antidepressants

14 May 2007

Headlines 25 years ago this week....

22 January 2007

Second FDA drug imports "blitz" finds 80% come from Canada

9 February 2004

Novartis sells off old CNS drugs in USA

25 June 2001

Viagra "Should Be Prescribed On UK NHS"

18 November 1998

Call For FDA To Regulate Third-Party Patient Data

17 June 1998

Pierre Fabre Launches Navelbine In The UK

30 May 1997

First Approval Of P&U's Reboxetine

23 April 1997

Prozac Cost Savings Not Supported

29 July 1996

Acamprosate - An Integrative Therapy for Alcoholism

15 July 1996

B-MS' Nefazodone Launched In UK

17 April 1995

UK Approval For Efexor; Comparative Data

16 January 1995

B-MS' Nefazodone Launched In 1st Market

3 October 1994

Forecasts For Growth In Euro Psychotropic Markets

22 August 1994

CoCensys Sales Force Ahead Of Schedule

25 July 1994

CIBA AND COCENSYS IN PRODUCT LINK-UP

23 May 1994

PAROXETINE COST EFFECTIVENESS

23 May 1994

CLINICAL EFFICACY OF B-MS' NEFAZODONE

12 April 1993

FDA PANEL BACKS PAROXETINE APPROVAL

12 October 1992

ANTIDEPRESSANT DRUG COSTS

15 June 1992

SOTALOL BEST, SAYS ARRHYTHMIA STUDY

27 April 1992

DEPRESSION: THE COST TO SOCIETY

6 April 1992

DEPRESSION: THE COST TO SOCIETY

6 April 1992

Showing 1-23 of 23 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Is failure to adopt business process management putting the pharma industry at risk?
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Is failure to adopt business process management putting the pharma industry at risk?
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS